Healthtech startup BlueSemi bags Rs 500 crore

BlueSemi is a Hyderabad-based deep tech AIoT firm founded in May 2017 by Sunil Kumar Maddikatla. Their Needle-Free Glucometer, Eyva bags the large sum of Rs 500 crore.

BlueSemi is a Hyderabad-based deep tech AIoT firm founded in May 2017 by Sunil Kumar Maddikatla. Their Needle-Free Glucometer, Eyva bags the large sum of Rs 500 crore. BlueSemi was formed with the vision to leverage innovative and cutting-edge technology to promote a Preventive and Connected healthcare ecosystem.

Eyva is a non-invasive glucometer that when placed on one's skin can read six biometrics within the span of 60 seconds. It checks one's sugar level, body temperature, ECG, heart rate, SpO2 for blood oxygen along blood pressure. Their product Eyva is pocket-friendly and costs upwards of 15,000. Based on the metrics the app can recommend diet, exercise and other ways to take care of your health. 

For COVID, the company had created Sens, a contactless temperature measuring solution. The venture was founded by IIIT-Hyderabad's postgraduate. BlueSemi had received $300,000 in seed funds and $166,000 in an angel round. Eyva helps people make informed choices regarding their food and its response to the body. 

According to the International Diabetes Federation (IDF), as many as 463 million people are suffering from diabetes globally. Nearly, 77 million people belong to India alone. Yet preventive healthcare for diabetes is scarce in the 'Diabetes Capital' of the world.

Tags : #BlueSemi #SunilKumarMaddikatla #Eyva #diabetes #glucometer #funding #fundingalert #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Innovative AI Assistance Empowers Moscow Doctors to Detect Cervical Spine Issues through MRI ScansApril 20, 2024
Air India Express ties up with AISATS for AeroWash Automated Aircraft Exterior Cleanings April 19, 2024
IndoSup raises strategic funding led by CCI group promoters Naresh Sharma and Satish Sharma; investors include Yatra.com’s Rohan Mittal April 19, 2024
10 compelling reasons why choosing right media platform Is important in healthcareApril 19, 2024
Protecting Public Health: Proposed Guidelines for Pharmaceutical Product DistributionApril 19, 2024
What is Haemophilia: A Genetic Bleeding Disorder that has Affected 1,36,000 IndiansApril 19, 2024
Climate Change and Stroke Risk: Exploring the Impact of Temperature Fluctuations on Your Body April 19, 2024
The Extension and Benefits of ABHA Linking with CGHS Beneficiary ID: What You Need to KnowApril 19, 2024
Mental Health Issues Impact Studies in 3 out 4 Female Students: PeakMind StudyApril 18, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 18, 2024
MiracleMe Introduces Revolutionary Orally Dissolving Plant-Based Nutrition ProductsApril 18, 2024
South Indian Bank signs MOU with Ashok Leyland Limited for Dealer FinancingApril 18, 2024
Serum Institute of India Partners with Oxford University to Develop Meningitis-B VaccineApril 18, 2024
Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income CountriesApril 18, 2024
Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024